{"id":"https://openalex.org/W4401435912","doi":"https://doi.org/10.1093/bjd/ljae266.053","title":"679 - Rocatinlimab significantly improves clinical responses in patients with moderate-to-severe atopic dermatitis by week 2 in a randomized double-blind placebo-controlled phase 2b study","display_name":"679 - Rocatinlimab significantly improves clinical responses in patients with moderate-to-severe atopic dermatitis by week 2 in a randomized double-blind placebo-controlled phase 2b study","publication_year":2024,"publication_date":"2024-08-01","ids":{"openalex":"https://openalex.org/W4401435912","doi":"https://doi.org/10.1093/bjd/ljae266.053"},"language":"en","primary_location":{"id":"doi:10.1093/bjd/ljae266.053","doi":"https://doi.org/10.1093/bjd/ljae266.053","is_oa":false,"landing_page_url":"https://doi.org/10.1093/bjd/ljae266.053","pdf_url":null,"source":{"id":"https://openalex.org/S45720283","display_name":"British Journal of Dermatology","issn_l":"0007-0963","issn":["0007-0963","1365-2133"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Dermatology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024365532","display_name":"Emma Guttman\u2010Yassky","orcid":"https://orcid.org/0000-0002-9363-324X","observed_orcids":["https://orcid.org/0000-0002-9363-324X"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emma Guttman-Yassky","raw_affiliation_strings":["Icahn School of Medicine at Mount Sinai , New York, NY , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Icahn School of Medicine at Mount Sinai , New York, NY , USA","institution_ids":["https://openalex.org/I98704320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081579877","display_name":"Ehsanollah Esfandiari","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ehsanollah Esfandiari","raw_affiliation_strings":["Kyowa Kirin , Marlow , UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kyowa Kirin , Marlow , UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031032841","display_name":"Hirotaka Mano","orcid":"https://orcid.org/0000-0003-0103-7748","observed_orcids":["https://orcid.org/0000-0003-0103-7748"]},"institutions":[{"id":"https://openalex.org/I205823427","display_name":"Kyowa Kirin (Japan)","ror":"https://ror.org/000wej815","country_code":"JP","type":"company","lineage":["https://openalex.org/I205823427"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hirotaka Mano","raw_affiliation_strings":["Kyowa Kirin , Tokyo , Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kyowa Kirin , Tokyo , Japan","institution_ids":["https://openalex.org/I205823427"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051511062","display_name":"Takahiro Arai","orcid":"https://orcid.org/0000-0003-3153-5377","observed_orcids":["https://orcid.org/0000-0003-3153-5377"]},"institutions":[{"id":"https://openalex.org/I4387153310","display_name":"Kyowa Kirin (United States)","ror":"https://ror.org/024264v67","country_code":"US","type":"company","lineage":["https://openalex.org/I205823427","https://openalex.org/I4387153310"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Takahiro Arai","raw_affiliation_strings":["Kyowa Kirin , Princeton, NJ , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kyowa Kirin , Princeton, NJ , USA","institution_ids":["https://openalex.org/I4387153310"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023533946","display_name":"Kenji Kabashima","orcid":"https://orcid.org/0000-0002-0773-0554","observed_orcids":["https://orcid.org/0000-0002-0773-0554"]},"institutions":[{"id":"https://openalex.org/I22299242","display_name":"Kyoto University","ror":"https://ror.org/02kpeqv85","country_code":"JP","type":"education","lineage":["https://openalex.org/I22299242"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kenji Kabashima","raw_affiliation_strings":["Graduate School of Medicine, Kyoto University , Kyoto , Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Graduate School of Medicine, Kyoto University , Kyoto , Japan","institution_ids":["https://openalex.org/I22299242"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3918,"currency":"GBP","value_usd":5008},"apc_paid":null,"fwci":0.3697,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.51911811,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"191","issue":"Supplement_2","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atopic-dermatitis","display_name":"atopic dermatitis","score":0.9430000185966492},{"id":"https://openalex.org/keywords/ox40","display_name":"OX40","score":0.7630000114440918},{"id":"https://openalex.org/keywords/pruritus","display_name":"pruritus","score":0.9390000104904175},{"id":"https://openalex.org/keywords/eczema-area-and-severity-index","display_name":"Eczema Area and Severity Index","score":0.9300000071525574},{"id":"https://openalex.org/keywords/onset-of-action","display_name":"onset of action","score":0.7789999842643738},{"id":"https://openalex.org/keywords/dosing-frequency","display_name":"dosing frequency","score":0.527999997138977},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.41999998688697815},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.5950000286102295}],"concepts":[{"id":"https://openalex.org/C2780699399","wikidata":"https://www.wikidata.org/wiki/Q20708049","display_name":"Eczema Area and Severity Index","level":3,"score":0.9079074859619141},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8916774988174438},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.8425382375717163},{"id":"https://openalex.org/C2778329239","wikidata":"https://www.wikidata.org/wiki/Q268667","display_name":"Atopic dermatitis","level":2,"score":0.6927546262741089},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6563014388084412},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5178878307342529},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.455790638923645},{"id":"https://openalex.org/C2991744798","wikidata":"https://www.wikidata.org/wiki/Q608510","display_name":"Double blind","level":4,"score":0.4423934817314148},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4396761655807495},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.4197677969932556},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.4103122651576996},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.34008336067199707},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3324718773365021},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.20392188429832458},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1093/bjd/ljae266.053","doi":"https://doi.org/10.1093/bjd/ljae266.053","is_oa":false,"landing_page_url":"https://doi.org/10.1093/bjd/ljae266.053","pdf_url":null,"source":{"id":"https://openalex.org/S45720283","display_name":"British Journal of Dermatology","issn_l":"0007-0963","issn":["0007-0963","1365-2133"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Dermatology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4402106937","https://openalex.org/W4387014386","https://openalex.org/W4387014233","https://openalex.org/W4388736487","https://openalex.org/W4312057370","https://openalex.org/W4404293285","https://openalex.org/W4416660271","https://openalex.org/W7213890422","https://openalex.org/W4390655800","https://openalex.org/W4386415831"],"abstract_inverted_index":{"Abstract":[0],"Introduction/Background":[1],"Moderate-to-severe":[2],"atopic":[3],"dermatitis":[4],"(msAD)":[5],"can":[6],"cause":[7],"chronic":[8],"cycles":[9],"of":[10,16,25,31,33,150,285],"pruritus":[11],"and":[12,41,44,138,142,158,183,212,215,223,248,271,278],"scratching,":[13],"impacting":[14],"quality":[15],"life.":[17],"Objectives":[18],"To":[19,27],"evaluate":[20],"rocatinlimab":[21,34,63,89,110,126,156,167,200,229,256],"for":[22,67,101,251,260],"the":[23,29,213,283],"treatment":[24],"msAD":[26,51],"investigate":[28],"onset":[30,124],"action":[32],"on":[35],"pruritis":[36],"Numerical":[37],"Rating":[38],"scale":[39],"(pNRS)":[40],"Eczema":[42],"Area":[43],"Severity":[45],"Index":[46],"(EASI)":[47],"in":[48,79,146,171,184,198,241,263],"adults":[49,264],"with":[50,125,166,210,228,235,265],"Methods":[52],"A":[53],"multicenter,":[54],"randomized,":[55],"double-blind,":[56],"placebo-controlled":[57],"Phase":[58],"2b":[59],"trial":[60],"(NCT03703102)":[61],"evaluated":[62,128],"(anti-OX40":[64],"monoclonal":[65],"antibody)":[66],"msAD.":[68,266],"Primary":[69],"endpoint":[70],"achievement":[71],"(Percent":[72],"change":[73,152],"from":[74,153,238],"baseline":[75,141,154,239],"to":[76,175,191,206,231,245],"week":[77],"16":[78,233],"EASI)":[80],"has":[81],"been":[82],"presented.":[83],"Randomized":[84],"patients":[85],"(1:1:1:1:1)":[86],"received":[87],"subcutaneous":[88],"150mg/600mg":[90],"every":[91,97],"4":[92,189],"weeks":[93,99,253],"(Q4W)":[94],"or":[95,104],"300mg/600mg":[96],"2":[98,170,221],"(Q2W)":[100],"36":[102,247],"weeks,":[103],"placebo":[105,159],"(Weeks":[106],"0\u201318)":[107],"followed":[108],"by":[109,135,168,187,202,219,273],"(600mg":[111],"Q2W":[112,217],"Weeks":[113],"18\u201336).":[114],"All":[115],"cohorts":[116,157,173,186,201,218,244],"had":[117],"20-week":[118],"off-treatment":[119,281],"follow-up.":[120],"Results":[121],"Clinical":[122],"response":[123],"was":[127,163],"post-hoc":[129],"(N=267;":[130],"rocatinlimab:":[131],"n=210;":[132],"placebo:":[133],"n=57)":[134],"investigating":[136],"pNRS":[137,270],"EASI":[139,194,272],"between":[140,155],"Week":[143,169,188,203,220,232,246,274],"16.":[144],"Difference":[145],"least":[147],"squares":[148],"mean":[149],"percent":[151],"were":[160,196,249,279],"assessed.":[161],"Pruritus":[162],"significantly":[164],"improved":[165,269],"all":[172,185,199,242],"(\u221218.40%":[174],"\u221221.96%;":[176],"p\u22640.018)":[177],"except":[178],"600mg":[179,216],"Q4W":[180],"(\u22129.66%;":[181],"p=0.208),":[182],"(\u221215.70%":[190],"\u221227.19%;":[192],"p\u22640.045);":[193],"improvements":[195,227,237,276],"significant":[197],"6":[204],"(\u221220.50%":[205],"\u221232.13%;":[207],"p\u22640.001)":[208],"compared":[209,234],"placebo,":[211],"300mg":[214],"(\u221213.27%":[222],"\u221213.66%;":[224],"p\u22640.028).":[225],"Further":[226],"continued":[230,240,277],"placebo;":[236],"active":[243],"maintained":[250,280],"20":[252],"off-treatment,":[254],"suggesting":[255],"may":[257],"have":[258],"potential":[259],"disease":[261],"modification":[262],"Conclusion":[267],"Rocatinlimab":[268],"2;":[275],"until":[282],"end":[284],"study.":[286]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-08-09T00:00:00"}